At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Jun 28, 2007 topper james n Director Buy 4,281 11.48 - 11.50
Jun 28, 2007 topper james n Director Buy 4,734 11.32 - 11.47
Jun 27, 2007 topper james n Director Buy 52,788 10.95 - 11.23
Jun 27, 2007 topper james n Director Buy 91,612 11.11 - 11.50
Jun 5, 2007 topper james n Director Acquisition (Non Open Market) 2,600,014 n/a
May 24, 2011 valenzano ken Officer Option Execute 2,250 0.64
May 24, 2011 valenzano ken Officer Sell 2,250 7.50
May 10, 2010 valenzano ken Officer Statement of Ownership 0 n/a
Aug 14, 2008 weinhoff gregory m Director Sell 50,000 17.00
Jun 5, 2007 weinhoff gregory m Director Acquisition (Non Open Market) 1,975,223 n/a
May 30, 2007 weinhoff gregory m Director Statement of Ownership 0 n/a
Nov 13, 2012 winterbottom joan Officer Buy 1,665 4.54
Showing 381-392 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy